Eur J Plast Surg (2012) 35:317–319 DOI 10.1007/s00238-011-0570-5 CASE REPORT Injection of transcutaneous botulinum toxin as a temporary treatment option for congenital eyelid retraction Érika Malheiros Bastos & Rafael Denadai Pigozzi Silva Received: 7 October 2010 /Accepted: 7 March 2011 /Published online: 29 April 2011 Springer-Verlag 2011 Introduction observed. Here, we propose a new non-surgical procedure for the temporary treatment of congenital eyelid retraction Although eyelid retraction is the most common clinical based on botulinum toxin injections for the exophthalmos characteristic of Graves' ophthalmopathy [1, 2], congenital improvement in the Graves' disease. eyelid retraction is a relatively rare condition [3–5]. It can affect the upper eyelid, the lower eyelid or both [3, 6]. For the diagnosis, the upper eyelid on the affected side Case report should be above the limbus, with a difference of at least 0.5 mm between the upper levels of the upper eyelids on both A 27-year-old woman was referred to the surgery depart- sides [3, 5]. The presence of retraction from birth and ment presenting a history of eyelid asymmetry since she absence of other causes of eyelid retraction, such as trauma, was born. This was confirmed by childhood photographs. thyroid disease, proptosis, abnormalities of
European Journal of Plastic Surgery – Springer Journals
Published: Apr 1, 2012
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera